vs
Side-by-side financial comparison of Evolus, Inc. (EOLS) and HARTE HANKS INC (HHS). Click either name above to swap in a different company.
Evolus, Inc. is the larger business by last-quarter revenue ($73.1M vs $39.9M, roughly 1.8× HARTE HANKS INC). HARTE HANKS INC runs the higher net margin — 5.5% vs -14.6%, a 20.1% gap on every dollar of revenue. On growth, Evolus, Inc. posted the faster year-over-year revenue change (6.7% vs -15.4%). Over the past eight quarters, Evolus, Inc.'s revenue compounded faster (4.6% CAGR vs -6.4%).
Evolus, Inc. is a medical aesthetics company focused on developing and commercializing non-surgical cosmetic treatment solutions. Its flagship product is a prescription neuromodulator designed to reduce moderate to severe glabellar frown lines, serving licensed aesthetic healthcare providers and consumers across North America, Europe, and key Asia-Pacific regional markets.
Harte Hanks is a global marketing services company headquartered in Boston, Massachusetts. Harte Hanks services include analytics, strategy, marketing technology, creative services, digital marketing, customer care, direct mail, logistics, and fulfillment.
EOLS vs HHS — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $73.1M | $39.9M |
| Net Profit | $-10.7M | $2.2M |
| Gross Margin | 66.9% | — |
| Operating Margin | 23.8% | -0.3% |
| Net Margin | -14.6% | 5.5% |
| Revenue YoY | 6.7% | -15.4% |
| Net Profit YoY | — | — |
| EPS (diluted) | $-0.16 | $0.30 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $73.1M | — | ||
| Q4 25 | $90.3M | $39.9M | ||
| Q3 25 | $69.0M | $39.5M | ||
| Q2 25 | $69.4M | $38.6M | ||
| Q1 25 | $68.5M | $41.6M | ||
| Q4 24 | $78.9M | $47.1M | ||
| Q3 24 | $61.1M | $47.6M | ||
| Q2 24 | $66.9M | $45.0M |
| Q1 26 | $-10.7M | — | ||
| Q4 25 | $130.0K | $2.2M | ||
| Q3 25 | $-15.7M | $-2.3M | ||
| Q2 25 | $-17.1M | $-335.0K | ||
| Q1 25 | $-18.9M | $-392.0K | ||
| Q4 24 | $-6.8M | — | ||
| Q3 24 | $-19.2M | $142.0K | ||
| Q2 24 | $-11.3M | $-27.8M |
| Q1 26 | 66.9% | — | ||
| Q4 25 | 65.7% | — | ||
| Q3 25 | 66.5% | — | ||
| Q2 25 | 65.3% | — | ||
| Q1 25 | 68.1% | — | ||
| Q4 24 | 66.7% | — | ||
| Q3 24 | 68.9% | — | ||
| Q2 24 | 70.3% | — |
| Q1 26 | 23.8% | — | ||
| Q4 25 | 4.7% | -0.3% | ||
| Q3 25 | -16.7% | 1.3% | ||
| Q2 25 | -14.7% | 0.1% | ||
| Q1 25 | -22.1% | -0.1% | ||
| Q4 24 | -2.9% | -3.3% | ||
| Q3 24 | -25.3% | 4.0% | ||
| Q2 24 | -11.5% | 3.0% |
| Q1 26 | -14.6% | — | ||
| Q4 25 | 0.1% | 5.5% | ||
| Q3 25 | -22.8% | -5.8% | ||
| Q2 25 | -24.7% | -0.9% | ||
| Q1 25 | -27.6% | -0.9% | ||
| Q4 24 | -8.6% | — | ||
| Q3 24 | -31.4% | 0.3% | ||
| Q2 24 | -17.0% | -61.8% |
| Q1 26 | $-0.16 | — | ||
| Q4 25 | $0.01 | $0.30 | ||
| Q3 25 | $-0.24 | $-0.31 | ||
| Q2 25 | $-0.27 | $-0.05 | ||
| Q1 25 | $-0.30 | $-0.05 | ||
| Q4 24 | $-0.11 | $-0.31 | ||
| Q3 24 | $-0.30 | $0.02 | ||
| Q2 24 | $-0.18 | $-3.84 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $49.8M | $5.6M |
| Total DebtLower is stronger | $156.4M | — |
| Stockholders' EquityBook value | — | $20.5M |
| Total Assets | $220.6M | $91.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $49.8M | — | ||
| Q4 25 | $53.8M | $5.6M | ||
| Q3 25 | $43.5M | $6.5M | ||
| Q2 25 | $61.7M | $4.8M | ||
| Q1 25 | $67.9M | $9.0M | ||
| Q4 24 | $87.0M | $9.8M | ||
| Q3 24 | $85.0M | $5.9M | ||
| Q2 24 | $93.7M | $11.0M |
| Q1 26 | $156.4M | — | ||
| Q4 25 | $146.1M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $121.8M | — | ||
| Q4 24 | $121.5M | — | ||
| Q3 24 | $121.2M | — | ||
| Q2 24 | $120.9M | — |
| Q1 26 | — | — | ||
| Q4 25 | $-23.1M | $20.5M | ||
| Q3 25 | $-28.8M | $19.9M | ||
| Q2 25 | $-18.7M | $22.2M | ||
| Q1 25 | $-6.6M | $21.4M | ||
| Q4 24 | $5.5M | $21.7M | ||
| Q3 24 | $5.9M | $21.0M | ||
| Q2 24 | $19.3M | $20.6M |
| Q1 26 | $220.6M | — | ||
| Q4 25 | $225.9M | $91.8M | ||
| Q3 25 | $219.0M | $92.7M | ||
| Q2 25 | $228.8M | $95.0M | ||
| Q1 25 | $213.4M | $100.6M | ||
| Q4 24 | $232.6M | $101.8M | ||
| Q3 24 | $229.6M | $108.1M | ||
| Q2 24 | $233.8M | $109.7M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 22.00× | — | ||
| Q3 24 | 20.58× | — | ||
| Q2 24 | 6.26× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $737.0K |
| Free Cash FlowOCF − Capex | — | $-686.0K |
| FCF MarginFCF / Revenue | — | -1.7% |
| Capex IntensityCapex / Revenue | — | 3.6% |
| Cash ConversionOCF / Net Profit | — | 0.33× |
| TTM Free Cash FlowTrailing 4 quarters | — | $-4.5M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $12.8M | $737.0K | ||
| Q3 25 | $-14.7M | $3.2M | ||
| Q2 25 | $-24.8M | $-4.8M | ||
| Q1 25 | $-15.6M | $-818.0K | ||
| Q4 24 | $4.8M | $4.0M | ||
| Q3 24 | $-5.7M | $-2.9M | ||
| Q2 24 | $-6.5M | $1.6M |
| Q1 26 | — | — | ||
| Q4 25 | $11.3M | $-686.0K | ||
| Q3 25 | $-15.6M | $2.2M | ||
| Q2 25 | $-25.5M | $-5.1M | ||
| Q1 25 | $-16.0M | $-923.0K | ||
| Q4 24 | $4.4M | $3.4M | ||
| Q3 24 | $-6.0M | $-4.9M | ||
| Q2 24 | $-6.9M | $926.0K |
| Q1 26 | — | — | ||
| Q4 25 | 12.6% | -1.7% | ||
| Q3 25 | -22.7% | 5.5% | ||
| Q2 25 | -36.7% | -13.1% | ||
| Q1 25 | -23.3% | -2.2% | ||
| Q4 24 | 5.5% | 7.3% | ||
| Q3 24 | -9.9% | -10.2% | ||
| Q2 24 | -10.4% | 2.1% |
| Q1 26 | — | — | ||
| Q4 25 | 1.6% | 3.6% | ||
| Q3 25 | 1.4% | 2.5% | ||
| Q2 25 | 1.0% | 0.6% | ||
| Q1 25 | 0.5% | 0.3% | ||
| Q4 24 | 0.6% | 1.3% | ||
| Q3 24 | 0.5% | 4.0% | ||
| Q2 24 | 0.7% | 1.5% |
| Q1 26 | — | — | ||
| Q4 25 | 98.67× | 0.33× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -20.76× | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
EOLS
| Product revenue, net | $72.7M | 99% |
| Service revenue | $390.0K | 1% |
HHS
| Fulfillment And Logistics Services | $17.3M | 43% |
| Customer Care | $13.7M | 34% |
| Other | $8.9M | 22% |
